Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Closed Posted
- Opportunity number
- PAR-25-040
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Special District Governments
- Higher Education Inst. (Public)
- Other
- State Governments
- Higher Education Inst. (Private)
- Independent School Districts
- County Governments
- City/Township Governments
- Tribal Governments (Federally Recognized)
- For Profit Organizations
- Small Businesses
- Public or Indian Housing Auth.
- Non-501(c)(3) Nonprofits
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
This Federal Grant Opportunity, titled "Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)," is seeking applications to advance translational research that can better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life. The funding is being provided by the Department of Health and Human Services' National Institutes of Health, specifically the National Institute of Mental Health (NIMH). The objective is to identify targets for future development of prevention and treatment efforts for these mental health conditions. Eligible applicants include a wide range of organizations such as state and local governments, higher education institutions, non-profits, and small businesses. The deadline to apply for this opportunity is September 7, 2026.
Typical awards under the parent Mental Health Research Grants program range from smaller exploratory grants around $50,000 to larger multi-year projects exceeding $3 million in total costs. Research activities are generally conducted at the facilities of the recipient organizations across the United States.
Synopsis
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity